Investor Relations

IR Home

Recent Newsmore >
11/01/17
ConforMIS Reports Third Quarter 2017 Financial Results
BILLERICA, Mass., Nov. 01, 2017 (GLOBE NEWSWIRE) -- ConforMIS, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are customized to fit each patient's unique anatomy, announced today financial results for the third quarter ended September 30, 2017. Q3 Summary: Total revenue of $18.4 million, down 1.2% year-over-year on a reported basis and down 1.6% on a co... 
10/16/17
Leader of Johnson & Johnson 3D Printing Center of Excellence Outlines Advantages of Customized Knee Implants
Orthopedic Industry Researches Additive Manufacturing and Customized Implants, While Body of Positive Clinical Results Related to ConforMIS Customized Knee Implant Systems Grows BILLERICA, Mass., Oct. 16, 2017 (GLOBE NEWSWIRE) -- ConforMIS, Inc. (NASDAQ:CFMS), a medical technology company that offers joint replacement implants customized to fit each patient's unique anatomy, today announced that, while the industry has begun to acknowledge the value of customized knee replacement implant syst... 
Upcoming Eventsmore >
01/08/18
ConforMIS presents at the 36th Annual J.P. Morgan Healthcare Conference
remind me days before the event

Enter your e-mail address 
IR Contact
Oksana Bradley
Investor Relations
Phone: (781) 374-5598
E-mail: ir@conformis.com

Media Contacts
Bill Berry
Berry & Company Public Relations
Phone: (212) 253-8881
E-mail: Bberry@berrypr.com

Lynn Granito
Berry & Company Public Relations
Phone: (212) 253-8881
E-mail: Lgranito@berrypr.com
Featured Reports
There are currently no items available.
Data provided by Nasdaq. Minimum 15 minutes delayed.